Trypanosoma cruzi infection in tumor necrosis factor receptor p55- deficient mice

Infection and Immunity

Volumn 66, Issue 6, 1998, Pages 2960-2968

  Castaños Velez, Esmeralda ^a   Maerlan, Stephanie ^b   Osorio, Lyda M ^b   Åberg, Frederik ^a   Biberfeld, Peter ^a   Örn, Anders ^b   Rottenberg, Martín E ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MANGANESE SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; IMMUNOREACTIVITY; INFECTION RESISTANCE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

EID: 2642647088     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.6.2960-2968.1998     Document Type: Article

References (60)

1. Bancroft, G. J., K. C. F. Sheehan, R. D. Shreiber, and E. R. Unanue. 1989. Tumour necrosis factor is involved in the T-cell independent pathway of macrophage activation in scid mice. J. Immunol. 143:127-135.
2. Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717-1725.
3. Black, C. M., D. M. Israelski, Y. Suzuki, and J. S. Remington. 1989. Effect of recombinant tumour necrosis factor on acute infection in mice with Toxoplasma gondii or Trypanosoma cruzi. Immunology 68:570-574.
4. Cardoni, R. L., M. E. Rottenberg, and E. L. Segura. 1990. Increased production of reactive oxygen species by spleen cells from mice acutely infected with Trypanosoma cruzi. Cell. Immunol. 128:11-21.
5. Chandrasekar, B., P. Melby, D. Troyer, and G. Freeman. 1996. Induction of proinflammatory cytokine expression in experimental acute chagasic cardiomyopathy. Biochem. Biophys. Res. Commun. 223:365-371.
6. + lymphocytes. Am. J. Trop. Med. Hyg. 48:637-644.
7. De Titto, E. H., J. R. Catterall, and J. S. Remington. 1986. Activity of recombinant tumor necrosis factor on Toxoplasma gondri and Trypanosoma cruzi. J. Immunol. 137:1342-1346.
8. Ding, A. H., C. F. Nathan, and D. J. Stuher. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2411.
9. Flynn, J., M. Goldstein, J. Chan, K. Triebold, K. Pfeffer, C. Lowestein, R. Schreiber, T. Mak, and B. Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572.
10. Gazzinelli, R. T., I. P. Oswald, S. Hieny, S. L. James, and A. Sher. 1992. The microbicidal activity of Interferon-γ treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitric oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β. Eur. J. Immunol. 22:2501-2506.
11. Gilbert, R. S., and H. R. Herschman. 1993. "Macrophage" nitric oxide synthase is a glucocorticoid-inhibitable primary response gene in 3T3 cells. J. Cell. Physiol. 157:128-132.
12. Gilliam, M., M. Sherman, J. Griscavage, and L. Ignarro. 1993. A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. Anal. Biochem. 212:359-365.
13. Golden, J., and R. L. Tarleton. 1991. Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity. Exp. Parasitol. 72:391-402.
14. Gonzalez Cappa, S. M., P. Chiale, G. E. del Prado, A. M. Katzin, G. W. de Martini, E. D. de Isola, L. A. Orrego, and E. L. Segura. 1980. Aislamiento de una cepa de Trypanosoma cruzi de un paciente con miocardiopatía chagásica crónica y su caracterización biológica. Medicina (Buenos Aires) 40:63-68.
15. Heller, R., K. Song, N. Fan, and D. Chang. 1992. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70:47-56.
16. Hir, M. L., H. Bluethmann, M. Bluethmann, M. Kosko-Vilbois, M. Müller, F. de Padova, M. Moore, B. Ryffel, and H. Eugster. 1996. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J. Exp. Med. 183:2367-2372.
17. Hiraoka, Y., C. Kishimoto, M. Kurokawa, H. Ochiai, and S. Sasayama. 1992. Effects of polyethylene glycol conjugated Superoxide dismutase on coxsackievirus B3 myocarditis in mice. Cardiovasc. Res. 26:956-961.
18. Hiraoka, Y., C. Kishimoto, H. Takada, M. Kurokawa, H. Ochiai, K. Shiraki, and S. Sasayama. 1993. Role of oxygen derived tree radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice. Cardiovasc. Res. 27:957-961.
19. Hirose, K., D. Lomgo, J. Oppenheim, and K. Matsushima. 1993. Overexpression of mitochondrial manganese Superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anti-cancer drugs and ionizing radiation. FASEB J. 7:361-368.
20. Hoff, R. 1975. Killing in vitro of Trypanosoma cruzi by macrophages from mice immunized with T. cruzi or BCG, and absence of cross-immunity on challenge in vivo. J. Exp. Med. 142:299-315.
21. Hsu, H., J. Xiong, and D. Goeddel. 1995. The TNF-receptor 1-associated protein TRADD signals cell death and NF-κβ activation. Cell 81:495-504.
22. Jacob, C., and M. Devitt. 1988. Tumor necrosis factor alpha in murine autoimmune "lupus" nephritis. Nature 331:356-358.
23. Kierszenbaum, F., and J. Howard. 1976. Mechanisms of resistance against Trypanosoma cruzi infection: the importance of antibodies and antibody forming capacity in the Biozzi high and low responder mice. J. Immunol. 116: 1208-1211.
24. Kierszenbaum, F., E. Knetch, D. B. Budzko, and M. C. Pizziment. 1974. Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi. J. Immunol. 112:1839-1844.
25. Lewis, M., L. Tartaglia, A. Lee, G. Bennet, F. Rcie, G. Wong, E. Chen, and D. Goeddel. 1991. Cloning and expression of cDNAs for two distinct tumor necrosis factor receptors demonstrate that one receptor is species specific. Proc. Natl. Acad. Sci. USA 88:2830-2839.
26. MacMicking, J., C. Nathan, G. Hom, N. Chartrain, D. Fletcher, M. Trumbauer, K. Stevens, Q. Xie, K. Sokol, and N. Hutchinson. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking induciblc nitric oxide synthase. Cell 81:641-650.
27. Matsumoto, M., S. Mariathasan, M. Nahm, F. Baranyay, J. Peschon, and D. Chaplin. 1996. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 264:703-707.
28. Metz, G., Y. Carlier, and B. Vray. 1993. Trypanosoma cruzi upregulates nitric oxide release by IFN-γ-preactivatcd macrophages, limiting cell infection independently of the respiratory burst. Parasite Immunol. 15:693-699.
29. Moncayo, A. 1993. Chagas' disease, p. 67-75. In Tropical disease research. Eleventh Program Report. World Health Organization. Geneva. Switzerland.
30. Munoz-Fernandez, M. A., M. A. Fernandez, and M. Fresno. 1992. Synergism between tumor necrosis factor and interferon-γ on macrophage activation for the killing ot intraccllular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J. Immunol. 22:301-307.
31. Penninger, J., N. Neu, and K. Bachmaier. 1996. A genetic map of autoimmune heart disease. The Immunologist 4:131-141.
32. Petray, P., E. C. Velez, S. Grinstein, A. Örn, and M. E. Rottenberg. 1995. Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi. Immunol. Lett. 47:121-126.
33. Pfeffer, K., T. Matsuyama, T. Kündig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. Ohashi, M. Krönke, and T. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxin shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
34. Rothe, M., S. Wong, W. Henzel, and D. Goeddel. 1994. A novel family of putative signal transducers associated with the cytoplasmatic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692.
35. Rottenberg, M., E. Castaños-Velez, R. Mesquita, O. Goñi Laguardia, P. Biberfeld, and A. Örn. 1996. Intracellular colocalization of inducible nitric oxide synthase and Trypanosoma cruzi: evidence for a dual pathway of iNOS induction. Eur. J. Immunol. 26:3203-3213.
36. Russo, M., N. Starobinas, R. R.-D. Santos, P. Minoprio, H. Eisen, and M. Hontebeyrie-Joskowicz. 1989. Susceptible mice present higher macrophage activation than resistant mice during infection with myotropic strains of Trypanosoma cruzi. Parasite Immunol. 11:385-395.
37. Russo, M., and N. Starobinas. 1991. Macrophage activation and resistance to Trypanosoma cruzi. Res. Immunol. 142:144-146.
38. Santos-Lima, E., I. Gracia, M. Vicentelli, P. Vasalli, and P. Minoprio. 1997. Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice. Infect. Immun. 65:457-465.
39. Senaldi, G., S. Yin, C. Shaklee, P. Piguet, T. Mak, and T. Ulrich. 1996. Corynebacterium parvum and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNFR-I) knockout mice and by treatment with soluble TNF-RI. J. Immunol. 157: 5022-5026.
40. Sher, A., I. Oswald, S. Hieny, and R. T. Gazzinelli. 1993. Toxoplasma gondii induces a T-cell independent interferon-γ response in NK cells which requires both adherent accessory cells and TNF-α. J. Immunol. 150:3982.
41. Shindo, T., U. Ikeda, F. Ohkawa, Y. Kawahara, M. Yokohama, and K. Shimada. 1995. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc. Res. 29:813-819.
42. Siehert, P. D., and J. W. Larrick. 1992. Competitive PCR. Nature 359: 557-559.
43. Silva, J., G. Vespa, M. Cardoso, J. Aliberti, and F. Cunha. 1995. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma-interferon-activated macrophages. Infect. Immun. 63:4862-4867.
44. Speicer, D., E. Sebzda, T. Ohteki, M. Bachmann, K. Pfeffer, T. Mak, and P. Ohashi. 1996. Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur. J. Immunol. 26:3055-3060.
45. Steinshamn, S., M. Bemelmans, L. van Tits, K. Bergh, W. Burman, and A. Waage. 1996. TNF receptors in murine Candida albicans infection. J. Immunol. 157:2155-2159.
46. Takehara, H., A. Perini, M. Da Silva, and I. Mota. 1981. Trypanosoma cruzi: role of different antibody classes in protection against infection in mice. Exp. Parasitol. 52:137-146.
47. Taliaferro, W. H., and T. Pizzi. 1955. Connective tissue reactions in normal and immunized mice to a reticulotropic strain of Trypanosoma cruzi. J. Infect. Dis. 96:199-226.
48. Tarleton, R. L. 1993. Pathology of American trypanosomiasis, p. 64-71. In K. S. Warren (ed.), Immunology and molecular biology of parasitic infections, 3rd ed. Blackwell Scientific Publications Ltd., Oxford, United Kingdom.
49. Tarleton, R. L. 1988. Tumour necrosis factor (cachectin) production during experimental Chagas' disease. Clin. Exp. Immunol. 73:186-191.
50. Tartaglia, L., R. Weber, I. Figari, C. Reynolds, M. Palladino, and D. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88:9292-9296.
51. Tripps, C., S. Wolf, and E. Unanue. 1993. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiological antagonist. Proc. Natl. Acad. Sci. USA 90: 3725-3729.
52. Trischmann, T. M., and B. R. Bloom. 1980. Trypanosoma cruzi: ability of T cell enriched and depleted lymphocyte populations to passively protect mice. Exp. Parasitol. 49:225-232.
53. Trischmann, T. M., H. Tanowitz, M. Wittner, and B. R. Bloom. 1978. Trypanosoma cruzi: role of the immune response in natural resistance of inbred strains of mice. Exp. Parasitol. 45:160-168.
54. Truyens, C., F. Torrico, A. Angelo-Barrios, R. Lucas, H. Heremans, P. de Batselier, and Y. Carlier. 1995. The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti-TNF-α, but not by anti-IL-6 or anti-IFN-γ antibodies. Parasite Immunol. 17:561-568.
55. Vespa, G., F. Cunha, and J. Silva. 1994. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 62:5177-5182.
56. Vieira, L., M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. Mak, and P. Scott. 1996. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157:827-835.
57. Wirth, J., and F. Kierszenbaum. 1988. Recombinant tumor necrosis factor enhances macrophage destruction of Trypanosoma cruzi in the presence of bacterial endotoxin. J. Immunol. 141:286-288.
58. Wong, G., and D. Goeddel. 1988. Induction of manganous Superoxide dismutase by tumor necrosis factor: possible protective mechanisms. Science 242:941-944.
59. Zhang, L., and R. Tarleton. 1996. Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infection. Exp. Parasitol. 84:203-213.
60. Zhou, T., C. Edwards, P. Yang, Z. Wang, H. Bluethmann, and J. Mountz. 1996. Greatly accelerated lymphoadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I. J. Immunol. 156:2661-2665.